Brokerages Set Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Target Price at $28.69

Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) have been given a consensus recommendation of “Hold” by the fifteen research firms that are currently covering the stock, MarketBeat reports. Two research analysts have rated the stock with a sell rating, five have given a hold rating, seven have issued a buy rating and one has issued a strong buy rating on the company. The average 12-month target price among brokers that have updated their coverage on the stock in the last year is $28.6923.

A number of analysts recently weighed in on ACHC shares. TD Cowen increased their price target on shares of Acadia Healthcare from $30.00 to $36.00 and gave the stock a “buy” rating in a research note on Tuesday, July 14th. Cantor Fitzgerald lifted their price objective on shares of Acadia Healthcare from $20.00 to $30.00 and gave the company a “neutral” rating in a research note on Friday, May 1st. Barclays upped their target price on shares of Acadia Healthcare from $20.00 to $25.00 and gave the company an “equal weight” rating in a report on Thursday, April 30th. KeyCorp increased their target price on shares of Acadia Healthcare from $30.00 to $40.00 and gave the stock an “overweight” rating in a research note on Tuesday, July 14th. Finally, Weiss Ratings reissued a “sell (d)” rating on shares of Acadia Healthcare in a report on Friday, June 12th.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently modified their holdings of the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. purchased a new stake in shares of Acadia Healthcare during the first quarter worth approximately $1,600,000. Goldman Sachs Group Inc. grew its position in Acadia Healthcare by 21.1% in the 1st quarter. Goldman Sachs Group Inc. now owns 698,225 shares of the company’s stock valued at $21,170,000 after buying an additional 121,444 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its position in Acadia Healthcare by 8.7% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 340,916 shares of the company’s stock valued at $10,337,000 after buying an additional 27,207 shares during the last quarter. American Century Companies Inc. increased its stake in Acadia Healthcare by 531.5% in the 2nd quarter. American Century Companies Inc. now owns 105,739 shares of the company’s stock valued at $2,399,000 after buying an additional 88,995 shares during the period. Finally, Prudential Financial Inc. raised its position in Acadia Healthcare by 21.9% during the 2nd quarter. Prudential Financial Inc. now owns 9,903 shares of the company’s stock worth $225,000 after buying an additional 1,780 shares during the last quarter.

Acadia Healthcare Trading Down 5.8%

ACHC opened at $32.50 on Friday. The company has a quick ratio of 1.71, a current ratio of 1.71 and a debt-to-equity ratio of 1.27. Acadia Healthcare has a 52 week low of $11.43 and a 52 week high of $35.83. The business’s 50 day moving average is $27.78 and its two-hundred day moving average is $23.36. The firm has a market cap of $2.99 billion, a price-to-earnings ratio of -2.66, a price-to-earnings-growth ratio of 11.51 and a beta of 0.64.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings data on Wednesday, April 29th. The company reported $0.37 earnings per share for the quarter, beating the consensus estimate of $0.28 by $0.09. The business had revenue of $828.80 million during the quarter, compared to the consensus estimate of $823.51 million. Acadia Healthcare had a positive return on equity of 7.09% and a negative net margin of 32.84%.The company’s revenue was up 7.6% compared to the same quarter last year. During the same period in the prior year, the company earned $0.40 earnings per share. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. On average, research analysts predict that Acadia Healthcare will post 1.5 EPS for the current year.

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.